Michelle Harlan, who has sickle beta thalassemia, wants to help others by getting a doctoral degree in clinical psychology.

Beam Therapeutics reported promising Phase 1/2 data for BEAM-302, demonstrating durable gene correction for AATD. See why I ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

Thalassemia, a genetic blood disorder, affects thousands of people in Telangana and Hyderabad, yet awareness and understanding of the condition remain limited. We spoke to Chandrakant Agarwal ...